Pfizer–BioNTech’s Omicron- adapted COVID-19 vaccine receives CHMP recommendation for EU market
GLOBAL — Pfizer Inc. and BioNTech SE have announced that the European Medicines Agency’s...
Read MoreSelect Page
Sep 27, 2024
GLOBAL — Pfizer Inc. and BioNTech SE have announced that the European Medicines Agency’s...
Read MoreSep 12, 2024
BOTSWANA—The Ministry of Health of Botswana, in collaboration with Ginkgo Bioworks LLC, has...
Read MoreAug 27, 2024
JAPAN— Moderna, Inc., a global pioneer in mRNA medication development, has been granted permission...
Read MoreJul 4, 2024
TANZANIA—The East African Community (EAC) has successfully tested the activation of its...
Read MoreJun 7, 2024
USA—The US Food and Drug Administration (FDA) has recommended the development of updated COVID-19...
Read MoreMay 9, 2024
UK -AstraZeneca, the British-Swedish pharmaceutical company, has announced the withdrawal of its...
Read MoreMay 7, 2024
USA – Moderna Inc., a pioneering force in mRNA medicine, grappled with significant financial...
Read MoreMay 7, 2024
USA – Pfizer, the pharmaceutical giant has reported a significant decline in its financial...
Read MoreMay 3, 2024
AFRICA—AstraZeneca, a global research-based biopharmaceutical corporation, has acknowledged for...
Read MoreMar 28, 2024
SWITZERLAND—The World Health Organization (WHO) has inaugurated a new laboratory network called...
Read More